FCGR3A Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lower-Grade Glioma

Figure 2

FCGR3A mRNA expression in LGG was determined with (a) GEPIA and in LGG patients with (b) different grades. (c) Histological subtypes and (d) TP53 mutation status were determined with ULACAN.

(a)

(b)

(c)

(d)